Pharmaceutical analytical development focuses on creating and evaluating analytical procedures suitable for measuring the quality attributes of drug substances and drug products. These procedures may be used during formulation development, stability studies, quality control and regulatory submissions.
KMS Pharma supports pharmaceutical development with a science-led approach that considers product characteristics, analytical objectives, method performance and documentation needs. The scope of analytical work should be defined according to the product, development stage and intended use of each procedure.
What is pharmaceutical analytical development?
Pharmaceutical analytical development is the process of designing, optimising and assessing test procedures used to evaluate drug substances, excipients and finished products. These methods help generate data about product identity, assay, purity, impurities and other relevant quality attributes.
An analytical procedure should be appropriate for its intended purpose. The development strategy considers the properties of the material, the quality attribute being measured, the required sensitivity and selectivity, and how the results will be used. The method may then be assessed, validated or transferred as appropriate for its intended application.
Define the analytical objective and the attribute that needs to be measured.
Select a suitable analytical technique based on product and method requirements.
Evaluate method performance using scientifically justified studies.
Maintain clear records of the procedure, results, investigations and conclusions.
Analytical method development for pharmaceutical products
Analytical method development starts by understanding what needs to be measured and the characteristics of the sample. The procedure must be able to distinguish the target analyte from relevant components in the sample matrix and produce data suitable for the intended decision.
Depending on the product and analytical objective, development may involve evaluating chromatographic conditions, sample preparation, extraction, detection settings, reference standards and system suitability requirements. Conditions are refined based on experimental findings rather than assumptions alone.
Define the measurement
Identify the analyte or quality attribute, sample type, expected range and intended use of the result.
Select the approach
Choose a suitable analytical technique based on sample properties, method requirements and available evidence.
Evaluate method conditions
Assess relevant parameters to improve separation, response, repeatability and practical method performance.
Confirm suitability
Review the generated data and determine whether the procedure meets its predefined analytical objectives.
The final method and its performance criteria should reflect the intended application. A procedure developed for one product or purpose may need additional evaluation before it is used for another.
Why analytical method validation matters
Analytical method validation provides documented evidence that a procedure is suitable for its intended purpose. The validation plan should be designed around the method's use, the type of measurement and the applicable regulatory and compendial expectations.
Depending on the analytical procedure, relevant performance characteristics may include specificity or selectivity, accuracy, precision, detection limit, quantitation limit, linearity and range. Not every characteristic applies in the same way to every method; selection and acceptance criteria require scientific justification.
Prepare the validation plan
Define the method's intended use, performance characteristics, study design and acceptance criteria before testing.
Conduct appropriate studies
Generate data to assess the performance characteristics relevant to the method and its intended application.
Review and document results
Evaluate the results against predefined criteria, investigate relevant deviations and document the conclusion on method suitability.
ICH Q2(R2) provides guidance on validation of analytical procedures, while ICH Q14 describes science- and risk-based approaches to analytical procedure development and lifecycle management. Applicability should be assessed against the product, method and relevant regulatory pathway.
Impurity profiling and degradation product analysis
Impurity profiling helps characterise and evaluate impurities that may be present in a drug substance or drug product. Potential sources can include starting materials, process-related impurities, degradation products and other impurities associated with the product or manufacturing process.
The analytical strategy depends on the type of product, the likely sources of impurities, the expected levels and the applicable reporting or control requirements. Method development may need to consider separation from the main component, detection capability and the suitability of the procedure for the relevant impurity range.
Understand impurity origins
Review process knowledge, raw materials and potential degradation pathways to identify relevant analytical needs.
Develop suitable separation
Evaluate whether the procedure can distinguish the target analyte from relevant impurities and degradation products.
Assess analytical response
Consider the detection and quantitation needs for the intended impurity assessment.
Support product understanding
Use appropriate analytical data to inform impurity evaluation and product quality decisions.
Impurity identification, qualification and control requirements are product-specific. Analytical findings should be interpreted alongside the relevant scientific evidence and regulatory expectations.
Stability-indicating analytical methods
Stability-indicating methods are designed to assess relevant quality attributes of a product in the presence of potential degradation products. They are important for interpreting changes that may occur during storage and for supporting product stability studies.
Depending on the product, analytical development may include appropriate stress studies, evaluation of degradation behaviour and assessment of whether the method can distinguish the active ingredient from relevant degradation products. The study design should be justified for the specific product and its known or anticipated risks.
Stability testing generates information about how product quality changes under defined conditions over time. Results can inform formulation selection, packaging considerations, storage recommendations and regulatory documentation. The appropriate testing programme depends on the product and applicable guidance.
Analytical techniques used in pharmaceutical development
The choice of analytical technique depends on the material being examined, the characteristic being measured and the sensitivity and selectivity needed. A technique should be selected because it addresses the analytical question, not simply because it is commonly used.
These are examples of commonly used analytical approaches, not a statement that every technique is available for every project. The actual method selection and scope should be confirmed against the product requirements and the capabilities required for the work.
Apply QbD and risk-based principles to analytical development
Quality by Design principles can support a structured understanding of analytical procedures. A science- and risk-based approach begins with the intended analytical purpose, identifies factors that may affect performance and uses suitable studies to build knowledge of the method.
Where appropriate, planned experiments can help evaluate the influence of method parameters and their interactions. The findings can inform method robustness, parameter selection and a suitable analytical control strategy. The extent of this work should be proportionate to the method's complexity, intended use and risk.
Define analytical objectives
Specify the quality attribute to measure and the performance needed for the intended decision.
Identify critical method parameters
Evaluate which variables could influence the method's performance and prioritise them using a justified risk assessment.
Build method knowledge
Use appropriate experiments and documented evidence to support method optimisation and ongoing control.
Analytical data, documentation and reproducibility
Analytical results are useful only when they can be interpreted in context and supported by appropriate records. Clear documentation helps explain how a procedure was developed, how studies were performed, what results were obtained and how conclusions were reached.
Depending on the activity, documentation may include method development records, protocols, raw data, calculations, system suitability results, chromatograms, validation reports, deviations and investigations. Records should follow the applicable quality system and data-integrity requirements.
Use approved procedures and documented study plans where required.
Maintain traceable analytical records and appropriate review of results.
Record deviations, investigations and scientifically justified conclusions.
Keep development and validation documentation aligned with the intended application.
Analytical development for regulatory submissions
Analytical data can contribute to regulatory documentation for drug substances and drug products. Depending on the submission, this may include analytical procedures, validation results, specifications, impurity information and stability data.
A well-documented analytical development process helps explain why a method was selected, how its performance was assessed and why it is suitable for its intended purpose. Analytical procedure development and validation should be planned with the relevant regulatory expectations in mind.
ICH Q14 addresses analytical procedure development, while ICH Q2(R2) covers analytical procedure validation. Applicable requirements can differ by product, market and submission type, so regulatory expectations should be confirmed for each project.
How to choose a pharmaceutical analytical development company
When selecting a pharmaceutical analytical development company, consider whether its technical approach fits the product and the decisions the analytical data needs to support. Discuss the scope of work, analytical objectives, applicable quality requirements and the documentation expected at each stage.
Experience relevant to the product type and analytical challenge.
A clear method development strategy with defined analytical objectives.
A scientifically justified method validation or verification plan, as applicable.
Consideration of impurity assessment and stability-indicating requirements.
Appropriate data handling, documentation and quality-system practices.
An understanding of the analytical information required for the intended regulatory pathway.
Reviewing these factors early can help establish a clear project scope, identify data gaps and align expectations for method development, validation and reporting.
Discuss your pharmaceutical analytical development needs
Connect with KMS Pharma to discuss your product, analytical objectives, method development requirements and the data needed to support further pharmaceutical development.
Contact KMS Pharma